Hyperproliferative diseases of the epidermal keratinocytes, such as psoriasis vulgaris, are characterized by overexpression and altered distribution of the epidermal growth factor/ transforming growth factor (EG F /TG F)-a receptor, and of TGF-a itself. It is believed that overexpression of this lignad/receptor system contributes to the hyperproliferative state ofkeratinocytes in an autocrine fashion. However, little is known about the factors that regulate expression of the EGF /TGF-a receptor, as well as expression of TGF-a in stratified epithelium. We examined modulation of the immunoreactive EGF/TGF-a receptor and TGF-a eXfression in normal neonatal foreskin explants by a variety 0 cytokines present in psoriatic lesions. Human (l1U) recombinant (r) tumor necrosis factor (TNF)-a and interferon (IFN)-y induced EGF/TGF-a receptor and TGF-a expression by kera-tinocytes as determined by immunohistochemistry. Neut~al izing antibodies to TNF-a and IFN-y inhibited upregulatlO n ofEGF /TGF-a receptors and TGF-a by the respective cytokines. Interleukin (IL)-8 induced expression of TGF-a, but not of its receptor. Other cytokines (TNF-P, IFN-P, IL-l~, IL-2, IL-3, IL-S, IL-6, granulocyte/macrophage colony-sUmulating factor, and macrophage colony-stimulating factor) did not alter the expression patterns of EGF/TGF-a receptors or TGF-a in normal neonatal skin explants. These eXperiments demonstrate that specific cytokines known t? be present in psoriatic lesions can induce normal epidermIS to express TGF-a and its receptor in a pattern similar to that observed in psoriatic skin. ] Invest Dermato! 99:350-356, 1992 ---
Hyperproliferative diseases of the epidermal keratinocytes, such as psoriasis vulgaris, are characterized by overexpression and altered distribution of the epidermal growth factor/ transforming growth factor (EG F /TG F)-a receptor, and of TGF-a itself. It is believed that overexpression of this lignad/receptor system contributes to the hyperproliferative state ofkeratinocytes in an autocrine fashion. However, little is known about the factors that regulate expression of the EGF /TGF-a receptor, as well as expression of TGF-a in stratified epithelium. We examined modulation of the immunoreactive EGF/TGF-a receptor and TGF-a eXfression in normal neonatal foreskin explants by a variety 0 cytokines present in psoriatic lesions. Human (l1U) recombinant (r) tumor necrosis factor (TNF)-a and interferon (IFN)-y induced EGF/TGF-a receptor and TGF-a expression by kera-tinocytes as determined by immunohistochemistry. Neut~al izing antibodies to TNF-a and IFN-y inhibited upregulatlO n ofEGF /TGF-a receptors and TGF-a by the respective cytokines. Interleukin (IL)-8 induced expression of TGF-a, but not of its receptor. Other cytokines (TNF-P, IFN-P, IL-l~, IL-2, IL-3, IL-S, IL-6, granulocyte/macrophage colony-sUmulating factor, and macrophage colony-stimulating factor) did not alter the expression patterns of EGF/TGF-a receptors or TGF-a in normal neonatal skin explants. These eXperiments demonstrate that specific cytokines known t? be present in psoriatic lesions can induce normal epidermIS to express TGF-a and its receptor in a pattern similar to that observed in psoriatic skin. ] Invest Dermato! 99:350-356, 1992 -
T he epidermis is one of the few tissues that is mitotically active throughout the lifespan of the organism. Two structurally and functionally related growth factors, epidermal growth factor (EGF) and transforming growth factor-a (TGF-a), appear to contribute to the proliferation of normal human keratinocytes during embryologic development and in tissue culture [1, 2] . Addition ofTGF-a to cultured keratinocytes not only stimulates growth, but also induces endogenous TGF-a production, which is likely to amplify the growth response to exogenous TGF-a [3] . Proliferative effects of both growth factors, EGF and TGF-a, are mediated by activation of the tyrosine kinase moiety of the EGF /TGF-a receptor [4, 5] that is expressed on the surface of keratinocytes in vivo and in vitro [6) . Inhibition of the EG F /TG F-a receptor tyrosine kinase activity results in inhibition of keratinocyte proliferation [4] . Conversely, constitutive overexpression of TGF-a in the skin of transgenic mice, under the control of the human keratin K14 promoter, leads to epidermal thickening, reflecting increases in keratinocyte nU.mbers and cell hypertrophy [7] . These results indicate an autocrl ne role for TGF-a in keratinocyte growth in vivo. . Activation of the TGF-a -dependent autocrine loop in keratlll Ocytes may be regulated by cytokines. Various cytokines, such ad interleukin (IL)-1 [8] , tumor necrosis factor-alpha (TNF-a) [9] , an interferon-gamma (IFN-y) [10, 11 ] ' have been shown to increase steady-state TGF-a mRNA levels in cultured keratinocytes. In ~d dition, IFN-y appears to modulate EGF-receptor protein expreSSIOn of cultured keratinocytes. Both increased [12] and decreased [13} EGF-receptor expression was observed after IFN-y treatment 0 keratinocytes in culture.
. However, studies with cultured keratinocytes cannot mimic the potential complex interactions between cells of different types nor between keratinocytes in distinct differentiation states. We haver therefore, examined the effect of various cytokines on the pattern 1expression of TGF-a and the EGF /TGF-a receptor in organ cU tures of normal neonatal skin.
MATERIALS AND METHODS
Organ Culture Short-term organ cultures of skin samples -:v ere carried out as described [14, 15] Base medium (approximately 800,u1) containing cytokines was added. The epidermal surface of explants remained uncovered by cUlture medium. Explants were incubated at 37"C in a humidified Incubator. In control cultures medium was not supplemented with cy~okines, or cytokines were mixed with neutralizing antibodies pnor to addition to cultures. Explants were harvested after 24 h, embedded in OCT compound (Tissue-Tek, Miles, Inc., Elkhart, IN) , and snap-frozen at -70°C.
Cytokines, Antibodies, and Immunohistochemistry Explants were incubated with the following cytokines at different concentrations: human (hu) recombinant (r) IL-8 (Pepro Tech Inc., Rocky Hill, NJ) at 5, 10, and 25 ng/ml; hu rTNF-O' (Genentech, San Francisco, CA) at 500, 1,000, and 10,000 U/ml; hu rIFN-y (Genentech) at 500,1,000, and 10,000 U/ml; hu rIL-IO' (Genetics Institute, Cambridge, MA) at 25, '50, and 100 U /ml; hu r granulocyte/macrophage colony-stimulating factor (Genetics Institute) at 1,000 and 10,000 U / ml; hu r macrophage colony-stimulating facor (Genetics Institute) at 1,000 and 10,000 U /ml; hu rIL-3 (Genet-ICS Institute) at 700 and 1,400 U /ml; hu rIL-5 (Genetics Institute) at 50, 100, and 500 U /ml; hu rIL-6 (Genetics Institute) at 10, 20, and 4~ U/ml (Genetics Institute); hu rTNF-p (Cetus Corp., Emoryvdle, CA) at 1,000 and 10,000 U /ml; and hu rIFN-P (Genentech) at 1,000 and 10,000 U /m!. [19, 20] and with an anti-Eselectin (ELAM-l) antibody H4/18 [14] , kindly provided by Dr.
~lchael Bevilacqua. The bound first antibody was detected by the ectastain ABC Elite kit (Vector Laboratories, Burlingame, CA)
With AEc as chromagen. No counterstain was applied in order to Increase sensitivity. Photographs were taken with a Zeiss Photomicroscope III, using Kodak T-MAX 100 film.
RESULTS
Morphology and Viability of Skin Explants After 24 h of organ culture, the keratinocytes appeared intact and similar in ap-CYTOKINE MODULATION OF TGF-a AND ITS RECEPTOR 351 pearance to normal skin after hematoxylin-eosin staining (Fig lA) . To confirm cellular viability, sections were stained with antibodies that specifically recognize endothelial cell adhesion molecules. The entire vasculature of the graft was visualized using the anti-PECAM-l MoAb (Fig IB) , and illustrates that the endothelium was intact and expressing normal cell surface antigens. To determine if these cells could respond to cytokine stimulation, sections of organ cultures exposed to base medium (Fig le) and cultures exposed to 10,000 units of TNF-O! (Fig ID) for 24 h were stained for the presence of E-selectin. Although E-selectin was completely absent in control sections (Fig le) , a small percentage of vessels in the TNF-O!-treated culture showed clear expression ofE-selectin (arrowheads in Fig ID) . This relatively weak, but significant, upregulation of E-selectin at 24 h is similar to that reported by Messadi et al [14] . (Figs 2A and 4A) . After incubating samples with 1000 U / ml TNF-O' for 24 h, a marked increase in TGF-O! expression (4+) was noted in the intermediate and upper skin layers ( Fig 2B) . Also, in a few sectors, basal and suprabasal keratinocytes showed increased staining (2+) for TGF-O' (Fig 2B) . Upregulation ofTGF-O' was also observed when samples were treated with 500 U /ml of TNF-O' (not shown). Expression ofTGF-O' was somewhat reduced, as compared to untreated controls (Fig 2e) , when explants were incubated simultaneously with TNF-O! and MoAb 154.2.1, a neutralizing antibody to TNF-O'.
Incubation with IFN-y at 1000 U /ml, but not at 500 U /ml, similarly resulted in higher expression of TGF-O', although staining intensity was less (3+) than that observed after addition ofTNF-O! (Fig ID) . Incubation with IFN-yin the presence of MoAb B33 .' 1, a neutralizing antibody to IFN-y, prevented the upregulatiO! <)f TGF-O' expression ( Fig lE) .
Expression of the EGF/TGF-O' receptor was confined to basalsuprabasal cells in untreated control samples ( Fig 3A) . Following incubation with either TNF-O' (500 or 1000 U/ml) or IFN-y (1000 U /ml), keratinocytes in all layers of the epidermis were evenly stained for the EGF /TGF-O! receptor (Fig 3B,D) . Similar to results described for TGF-O!, upregulation of the EGF/TGF-O! receptor could not be observed when TNF-O'-or IFN-y-induced effects were inhibited with the respective neutralizing antibody ( Fig  3C, E) . Furthermore, treatment of cultures with the TNF-O' antibody alone resulted in reduced staining for the EG F /TG F-O' receptor when compared to untreated controls, suggesting that endogenous TNF-O' may contribute to EGF/TGF-O' receptor expression.
Effect ofIL-8 on TGF-O! and EGF /TGF-O! Receptor Expression in Skin Explants
Treatment of skin explants with 5 ng/ml hu rIL-8 resulted in a marked upregulation ofTGF-O! in all layers of the epidermis (4+ versus 1 or 2+ in controls) (Fig 4A,B) . Similar to results obtained with IFN-y, basal and suprabasal cells stained only weakly for TGF-O! in control cultures. No modulation of EGF/ TGF-O' receptor expression by IL-8 was observed in three consecutive experiments carried out on tissues from different donors (not shown).
Effects of Other Cytokines on TGF-O' and EGF /TGF-O' Receptor Expression in Skin Explants
No stimulation ofTGF-O! and EG F /TG F-O! receptor expression was detected in four consecutive experiments using material from different donors when skin explants were treated with hu rIL-IO!, IL-3, IL-5, or IL-6. Similarly, TNF-P, IFN-P, macrophage/colony-stimulating factor, and granulocyte macrophage/colony-stimulating factor were ineffective when tested in three separate experiments. -l (B) . The viability of the cells within the explants was determined by exposing organ cultures to base medium or 10,00 f~he ofTNF-a for 24 h and then staining for the inducible endothelial cell adhesion molecule, E-selectin. No expression ofE-selectin was seen on the vessel~~ J1.t11. control cu lture (C). In contrast, clear expression of E-selectin (arrowheads) was seen in some of the vessels in the TNF-a-treated graph (D) . Bars, Ftgure 4. Induction of TGF-a expression in skin explants by IL-8. Exp ants were incubated inMCDB base medium alone (AJ or 111 the presence of IL-8 (B J. Bars, 30, um. 
DISCUSSION
In Contrast to earlier studies on cultured keratinocytes, Out experirnents evaluated the cytokine-induced upregulation ofTGF-a and Its receptor on keratinocytes in situ. This approach takes into ac-COUnt that the net result of cytokine-mediated effects may be critically dependent on the complex interaction of different cell types b nd distinct differentiation states that are present in stratified skin, Ut absent in keratinocyte cu ltures. E The cytokine-induced expression pattern of immunoreactive GF /TG F-a receptors in normal neonatal skin is strikingly similar to the pattern observed in active psoriatic lesions. In stratified noral epithelium, expression of immunoreactive EGF /TGF-a recep-([ o;s IS restricted to basal and immediate suprabasal keratinocytes . 1] and this study) . However, in active psoriatic lesions, expres-Sl~n of EGF receptors is observed not only in the basal but also in the sb.comeal layers of stratified epithelium [6, 22] , reminiscent of the ~ IqUltouS expression ofEGF /TGF-a receptors in fetal skin [21] . In 11s study, TNF-a and IFN-y treatment of skin explants produced a uniform expression of EGF /TGF-a receptors across all nucleated 1trata of the epidermis, similar to the pattern observed in psoriatic eS10 ns Or fetal epidermis.
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Expression of immunoreactive TGF-a protein has been reported to be generally enhanced, but not significantly redistributed, in active psoriatic lesions when compared to normal skin or uninvolved skin from psoriatic patients [23 -25] . This finding is reflected by elevated TGF-a mRNA levels in psoriatic plaques [10, 24] . Enhanced expression of TGF-a mRNA [24] and protein [25] was observed, particularly in psoriatic suprabasal keratinocytes. This is the same location in which we found the strongest cytokineinduced increase of immunoreactive TGF-a in normal epidermis. At variance with findings ofTutbitt et al [24] , TGF-a immunostaining of basal normal keratinocytes in control explants was weak. However, treatment with IL-8 led to detection of elevated TGF-a protein levels not only in the suprabasal stratum but also in basal keratinocytes.
Out results suggest that the pattern of the EGF /TGF-a receptor and TGF-a expression as observed in psoriasis is not unique to this disease, but can be induced in normal neonatal skin and, thus, may be comparable to a physiologic response to cytokine stimulation of keratinocytes. Activated immune cells such as T-Iymphocytes, monocytes/macrophages, and Langerhans cells are obvious sources for cytokines such as IFN-y and TNF-a in active psoriatic lesions. In fact, Nickoloff et al [9] recently described that TNF-a is expressed predominantly by macrophages in the papillary dermis of psoriatic lesions, and focally by epidermal Langerhans cells and keratinocytes. Suprabasal keratinocytes immediately above dermal TNF-acontaining macrophages appear to produce IL-8 , suggesting a cascade of cytokine expression involving several cell types. IFN-y is a major cytokine released by activated T lymphocytes, and T lymphocytes are found at elevated levels in psoriatic skin (26] . Interestingly, elevated levels of IFN-y have been reported in sera of patients with psoriasis [27] , and patients with psoriasis injected with this cytokine to treat psoriatic arthropathy developed punctiform psoriatic foci at the injection site [28], suggesting a direct involvement of this cytokine in the pathogenesis of skin lesions in psoriasis. In contrast to TNF-a and IL-8, IFN-y has not been found to be produced by keratinocytes (for review see [29] ), although IFN-y mRNA was detected in psoriatic epidermis using the sensitive reverse transcription polymerase chain reaction [30] . Taken together, these results suggest that in psoriatic skin IFN-y may be produced by an epidermal cell type other than keratinocytes.
It should be noted that comparatively high levels of TNF-a (500 U /ml) and IFN-y (1000 U /ml) were needed to induce significant changes ofTGF-a and EGF /TGF-a receptor expression when compared to monolayer cultutes [11] . However, the cytokine concentrations used here are comparable to the levels ofIFN-y (100 and 200 U /ml) required to induce ICAM-l and HLA-OR on keratinocytes in situ [31] . By contrast to monolayer cultures, in the explant system access of cytokines to target cells is a critical determinant. Variables such as size of the skin explant, media composition, and modifications in technique may all influence diffusion of cytokines into the explant. In support of this notion, Griffiths et al [31] found that complete immersion of skin explants in culture medium leads to cytokine-induced expression of HLA-OR on keratinocytes, whereas partial immersion of primarily the dermal portion does not [15] . We chose to use the latter protocol based on the assumption that cytokines with possible relevance in vivo would gain access to keratinocytes by diffusion from the dermis up.
Of the other cytokines included in this study, 33] and IL-6 [34] have been found at elevated levels or differently distributed in psoriatic lesions as compared to normal skin. Under the experimental conditions chosen in this study, these two cytokines did not affect TGF-a or TGF-a/EGF receptor expression detectably. However, the role of these cytokines in these phenomena cannot be discounted. Cytokine-induced effects could only be evaluated within a short time period (24 h) after initiation of explant cultures. After this time period, cell viability decreased dramatically. It appears possible that some cytokines have indirect effects by triggering a sequence of e~ents that require a longer time period to evolve. In support of tillS notion, IL-l has been described to stimulate the production and release of IL-8 from keratinocytes [35, 36] .
Our results indicate that the pattern ofTGF-a and EGF /TGF-a receptor expression in human epidermis can be modulated by cytokines. Cytokines known to be present in psoriatic lesions enhance the intensity and/or expand the distribution of TGF-a and its receptor in normal epidermis, causing it to resemble the psoriatic state. We hypothesize that the altered expression ofTGF-a and its receptor observed in psoriatic lesions is secondary to an effect of a previously acting cytokine, either produced by infiltrating immune cells or the keratinocytes themselves.
